Company Search:
Advanced Search
Sponsored Links
Sygnis Ag Company Snapshot
Sygnis Ag operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sygnis Ag with three other miscellaneous service companies in Europe: Tigenix Nv of Belgium (2015 sales of 537,000.00 Euro [US$589,459.53 ] of which 100% was Pharmaceuticals), Arc Aroma Pure AB of Sweden (5.06 million Swedish Kronor [US$572,904.36 ] ), and Read-Gene SA which is based in Poland (2.19 million Polish New Zlotys [US$556,414.90 ] ).

Sales Analysis. During the year ended December of 2015, sales at Sygnis Ag were 555,000.00 Euro (US$609.22 thousand). This is an increase of 41.6% versus 2014, when the company's sales were 392,000.00 Euro. Sales of Other saw an increase that was more than double the company's growth rate: sales were up 1,342.9% in 2015, from 21,000.00 Euro to 303,000.00 Euro. Not all segments of Sygnis Ag experienced an increase in sales in 2015: sales of Licenses fell 16.3% to 252,000.00 Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sygnis Ag
  Stock Performance Chart for Sygnis Ag
  Stock Data: Recent Stock Performance:
  Current Price (10/14/2016): 1.29
(Figures in Euro)
1 Week 2.5%   13 Weeks 0.2%  
4 Weeks -0.5%   52 Weeks -42.2%  
Sygnis Ag Key Data:
  Ticker: LIO1 Country: Germany
  Exchanges: DUS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 555,000
(Year Ending Jan 2016).
Employees: 21
  Currency: Euro Market Cap: 23,680,768
  Fiscal Yr Ends: December Shares Outstanding: 18,357,184
  Share Type: Stammaktie Closely Held Shares: 8,957,515
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.